$ABOS
Acumen Pharmaceuticals, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Newton, MA
ABOS chart
What traders are saying about $ABOS
Latest postsAcumen Pharmaceuticals, Inc. news
- Acumen Pharmaceuticals Q3 2026: $78.6M Liquidity, $78.8M Nine-Month Net Loss
Minichart ·
- Form S-3 Acumen Pharmaceuticals Inc For: 27 October By Investing.com
Investing.com India ·
- Acumen Pharmaceuticals Q3 2026 Earnings: Clinical Inflection Point Amid Tightening Cash Runway
AlphaStreet ·
- Acumen Pharmaceuticals Inc (ABOS) (Q3 2026) Earnings Call Highlights: $79 Million Cash Runway ...
Yahoo Finance ·
- Acumen Pharmaceuticals - May Offer Up To $500 Million Of Securities - SEC Filing
TradingView ·
- Acumen Pharmaceuticals Releases Q3 2026 Financial Results
AlphaStreet ·
- Acumen Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings Call Transcript
fool.com ·
- Acumen Q3 Loss Narrows Ahead of November Trial Results
grafa.com ·
- Acumen Pharmaceuticals Reports Smaller Q3 Loss, Shares Rise as Phase 2 Alzheimer’s Data Approach
investorshub.advfn.com ·
- Acumen Pharmaceuticals Q3 Earnings Call Highlights
marketbeat.com ·
- Third quarter earnings update released by Acumen Pharmaceuticals
Traders Union ·
Acumen Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$121.3M | -$102.3M | -$52.4M | -$42.9M |
| Diluted EPS | $-2.00 | $-1.71 | $-1.08 | $-1.06 |
| Total assets (year end) | $122.8M | $239.0M | $310.1M | $196.6M |
| Cash and equivalents (year end) | $54.0M | $35.6M | $66.9M | $130.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Acumen Pharmaceuticals, Inc.
- Ticker
- ABOS (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Newton, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1576885
Frequently asked questions
What exchange is Acumen Pharmaceuticals, Inc. listed on?
Acumen Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ABOS.
What industry is Acumen Pharmaceuticals, Inc. in?
Acumen Pharmaceuticals, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Acumen Pharmaceuticals, Inc. headquartered?
Acumen Pharmaceuticals, Inc.'s business address on file with the SEC is in Newton, MA.
When does Acumen Pharmaceuticals, Inc.'s fiscal year end?
Acumen Pharmaceuticals, Inc.'s fiscal year ends on December 31.